AMLX - Amylyx Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.50
DETAILS
HIGH:
$40.00
LOW:
$24.00
MEDIAN:
$31.00
CONSENSUS:
$31.50
DOWNSIDE:
10.28%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-09 | Mazzariello Gina | officer: Chief Legal Officer | SELL | 15,000 | $18.32 | $275K |
| 2026-07-10 | Mazzariello Gina | officer: Chief Legal Officer | SELL | 15,000 | $17.61 | $264K |
| 2026-06-04 | Firestone Karen | director | A-Award | 24,372 | $14.31 | $349K |
| 2026-06-04 | MILNE GEORGE M JR | director | A-Award | 24,372 | $14.31 | $349K |
| 2026-06-04 | FONTEYNE PAUL R. | director | A-Award | 24,372 | $14.31 | $349K |
| 2026-06-04 | Quimi Daphne | director | A-Award | 24,372 | $14.31 | $349K |
| 2026-06-04 | Zeiher Bernhardt G | director | A-Award | 24,372 | $14.31 | $349K |
| 2026-05-21 | Firestone Karen | director | BUY | 3,800 | $13.51 | $51K |
| 2026-03-05 | Mazzariello Gina | officer: Chief Legal Officer | A-Award | 111,990 | $14.10 | $1.6M |
| 2026-03-05 | FRATES JAMES M | officer: Chief Financial Officer | A-Award | 95,990 | -- | -- |
| 2026-03-05 | FRATES JAMES M | officer: Chief Financial Officer | A-Award | 143,985 | $14.10 | $2.0M |
| 2026-03-05 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | A-Award | 248,865 | -- | -- |
| 2026-03-05 | Klee Justin B. | director, officer: Co-Chief Executive Officer | A-Award | 248,865 | -- | -- |
| 2026-03-05 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | A-Award | 373,295 | $14.10 | $5.3M |
| 2026-03-05 | Klee Justin B. | director, officer: Co-Chief Executive Officer | A-Award | 373,295 | $14.10 | $5.3M |
| 2026-03-05 | Mazzariello Gina | officer: Chief Legal Officer | A-Award | 74,660 | -- | -- |
| 2026-03-05 | Bedrosian Camille L | officer: Chief Medical Officer | A-Award | 95,990 | -- | -- |
| 2026-03-05 | Bedrosian Camille L | officer: Chief Medical Officer | A-Award | 143,985 | $14.10 | $2.0M |
| 2026-03-02 | Klee Justin B. | director, officer: Co-Chief Executive Officer | SELL | 29,282 | $14.47 | $424K |
| 2026-03-02 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | SELL | 29,282 | $14.48 | $424K |
| 2026-03-02 | Bedrosian Camille L | officer: Chief Medical Officer | SELL | 6,461 | $14.58 | $94K |
| 2026-03-02 | FRATES JAMES M | officer: Chief Financial Officer | SELL | 7,909 | $14.52 | $115K |
| 2026-03-02 | Mazzariello Gina | officer: Chief Legal Officer | SELL | 6,844 | $14.52 | $99K |
| 2026-02-23 | Mazzariello Gina | officer: Chief Legal Officer | SELL | 3,419 | $14.14 | $48K |
| 2026-02-02 | Cohen Joshua B | director, officer: Co-Chief Executive Officer | SELL | 15,500 | $14.68 | $228K |